Investors

In June 2017, JSR acquired Selexis as part of its Life Sciences Group’s commitment to offer industry partners best-in-class contract development manufacturing (CDMO) services. Selexis SA and KBI Biopharma, which was acquired by JSR in 2015, have joined forces to provide industry partners “Gene to GMP in 9 Months”: the most robust and fastest service offering for the biopharmaceutical industry.

Full Press Release